Please assess the completion status of the following clinical trial:

Trial Title: Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Hidradenitis Suppurativa~* Prescribed Adalimumab according to the Summary of Product Characteristics (SmPC)~* Willingness to sign and date a Patient Information/Informed Consent Form~Exclusion Criteria:~* Prior biologic treatment discontinued \<6 months before the baseline visit~* Patient not able to understand the language of the provided patient questionnaires~* History of non-compliance with medication or a medical history that could enhance non-compliance with medication, as determined by the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Patients with Hidradenitis Suppurativa (Type: None): Patients with moderate or severe HS treated prescribed adalimumab according to the Swedish Summary of Product Characteristics and treated as per routine clinical practice.

Based on this trial design, predict the completion outcome and termination type (if applicable).